Ligand Pharmaceuticals Balance Sheet

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Cash & Equivalents	842.08	4,308	18,483	2,985	18,662	45,117	Upgrade
Trading Asset Securities	-	-	1,507	24.63	54,673	647	Upgrade
Cash & Short-Term Investments	842.08	4,308	19,990	3,010	73,335	45,764	Upgrade
Cash Growth	-63.90%	-78.45%	564.15%	-95.90%	60.25%	0.08%	Upgrade
Accounts Receivable	8,148	10,989	29,882	-	-	17.6	Upgrade
Other Receivables	21,662	26,286	14,428	3,068	113,822	-	Upgrade
Receivables	29,810	37,275	48,890	7,468	113,822	17.6	Upgrade
Inventory	83.41	21	-	-	-	455	Upgrade
Prepaid Expenses	6,738	151.98	-	-	-	-	Upgrade
Other Current Assets	2,612	7,252	295,526	8,519	20,822	198.05	Upgrade
Total Current Assets	40,086	49,008	364,405	18,996	207,979	46,434	Upgrade
Property, Plant & Equipment	49,988	53,051	54,701	52,076	13,367	405.62	Upgrade
Long-Term Investments	-	-	631	631	81	-	Upgrade
Other Intangible Assets	3,632	4,191	4,470	4,470	-	-	Upgrade
Long-Term Deferred Tax Assets	7,257	9,569	3,643	3,855	1,324	-	Upgrade
Long-Term Deferred Charges	-	-	-	21,483	-	-	Upgrade
Other Long-Term Assets	624,899	620,595	332,538	192,266	780.66	-	Upgrade
Total Assets	725,861	736,414	760,388	293,778	223,532	46,840	Upgrade
Accounts Payable	2,346	9,349	6,737	4,239	1,775	-	Upgrade
Accrued Expenses	19,092	9,425	4,427	5,121	22,115	5.16	Upgrade
Short-Term Debt	17,328	16,324	-	-	-	-	Upgrade
Current Portion of Long-Term Debt	-	8,958	-	-	-	-	Upgrade
Current Portion of Leases	2,062	3,058	2,527	2,223	2,012	-	Upgrade
Current Income Taxes Payable	-	5,987	3,439	4,461	405.95	11.85	Upgrade
Current Unearned Revenue	-	959.79	4,125	-	-	-	Upgrade
Other Current Liabilities	38,682	29,621	23,332	120,660	241.51	96.18	Upgrade
Total Current Liabilities	79,511	83,683	44,586	136,705	26,550	113.19	Upgrade
Long-Term Debt	57,577	46,813	38,544	67,903	-	-	Upgrade
Long-Term Leases	756.72	1,389	4,179	6,771	9,027	-	Upgrade
Long-Term Deferred Tax Liabilities	-	-	-	-	7.69	-	Upgrade
Other Long-Term Liabilities	-	-	-	-	165,724	-	Upgrade
Total Liabilities	139,076	133,117	93,749	215,041	201,640	429.12	Upgrade
Common Stock	634,722	634,722	634,722	35,860	35,860	35,860	Upgrade
Additional Paid-In Capital	25,611	25,611	25,611	47,095	12,586	12,586	Upgrade
Retained Earnings	-71,222	-55,747	7,056	4,101	-965.53	-2,266	Upgrade
Comprehensive Income & Other	-83.7	-83.7	52.49	-7,908	-25,589	230.69	Upgrade
Total Common Equity	589,028	604,502	667,441	79,147	21,892	46,411	Upgrade
Minority Interest	-2,243	-1,205	-802.31	-410.01	0.16	0.15	Upgrade
Shareholders' Equity	586,785	603,297	666,639	78,737	21,892	46,411	Upgrade
Total Liabilities & Equity	725,861	736,414	760,388	293,778	223,532	46,840	Upgrade
Total Debt	77,724	76,543	45,250	76,896	11,039	-	Upgrade
Net Cash (Debt)	-76,882	-72,234	-25,261	-73,887	62,296	45,764	Upgrade
Net Cash Growth	-	-	-	-	36.12%	0.08%	Upgrade
Net Cash Per Share	-12.06	-11.38	-3.98	-206.04	173.72	127.62	Upgrade
Filing Date Shares Outstanding	6,347	6,347	6,347	358.6	358.6	358.6	Upgrade
Total Common Shares Outstanding	6,347	6,347	6,347	358.6	358.6	358.6	Upgrade
Working Capital	-39,425	-34,675	319,819	-117,708	181,429	46,321	Upgrade
Book Value Per Share	92.80	95.24	105.15	220.71	61.05	129.42	Upgrade
Tangible Book Value	585,396	600,312	662,971	74,677	21,892	46,411	Upgrade
Tangible Book Value Per Share	92.23	94.58	104.45	208.25	61.05	129.42	Upgrade
Land	-	25,704	25,471	25,471	-	-	Upgrade
Machinery	-	11,992	9,832	9,617	4,554	3,566	Upgrade
Construction In Progress	-	-	7,223	-	-	-	Upgrade
Leasehold Improvements	-	-	-	-	-	207.46	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.